INBS Insider Trading

Insider Ownership Percentage: 0.28%
Insider Buying (Last 12 Months): $184.32
Insider Selling (Last 12 Months): $0.00

Intelligent Bio Solutions Insider Trading History Chart

This chart shows the insider buying and selling history at Intelligent Bio Solutions by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Intelligent Bio Solutions Share Price & Price History

Current Price: $2.41
Price Change: Price Increase of +0.1 (4.33%)
As of 05/22/2024 05:32 PM ET

This chart shows the closing price history over time for INBS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Intelligent Bio Solutions Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/31/2023Harry SimeonidisCEOBuy8$23.04$184.32344View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Intelligent Bio Solutions (NASDAQ:INBS)

32.97% of Intelligent Bio Solutions stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Intelligent Bio Solutions Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/20/2024Virtu Financial LLC12,537$53K0.0%N/A0.402%Search for SEC Filing on Google Icon
5/7/2024CVI Holdings LLC108,250$0.46M0.4%N/A3.812%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Intelligent Bio Solutions logo
Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Read More on Intelligent Bio Solutions

Today's Range

Now: $2.41
Low: $2.36
High: $2.50

50 Day Range

MA: $3.23
Low: $2.25
High: $4.59

52 Week Range

Now: $2.41
Low: $2.16
High: $44.88

Volume

47,261 shs

Average Volume

2,091,786 shs

Market Capitalization

$7.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

4.87

Who are the company insiders with the largest holdings of Intelligent Bio Solutions?

Intelligent Bio Solutions' top insider shareholders include:
  1. Harry Simeonidis (CEO)
Learn More about top insider investors at Intelligent Bio Solutions.

Who are the major institutional investors of Intelligent Bio Solutions?

Intelligent Bio Solutions' top institutional shareholders include:
  1. CVI Holdings LLC — 3.81%
  2. Virtu Financial LLC — 0.40%
Learn More about top institutional investors of Intelligent Bio Solutions stock.

Which institutional investors are buying Intelligent Bio Solutions stock?

Within the last quarter, INBS stock was bought by institutional investors including:
  1. CVI Holdings LLC
  2. Virtu Financial LLC